1. LEO Reports the US FDA’s Acceptance of BLA for Tralokinumab to Treat Adults with Moderate to Severe Atopic Dermatitis Published Date: Jul 10, 2020 | Tags: LEO, Reports, US, […]readmore
Tags : BioIntelliSense
Shots: Royal Philips collaborated with BioIntelliSense, to integrate its BioSticker medical device into Philips’ RPM offering to help monitor at-risk patients from the hospital into the home Addition of multi-parameter […]readmore
Shots: BioIntelliSense launches its medical-grade Data-as-a-Service (DaaS) platform and has received 510(k) clearance for BioSticker on-body sensor for scalable remote care in the US The company has developed BioSticker device […]readmore